Financials data is unavailable for this security.
View more
Year on year Humanwell Healthcare Group Co Ltd had net income fall -14.07% from 2.48bn to 2.13bn despite a 9.79% increase in revenues from 22.34bn to 24.52bn. An increase in the selling, general and administrative costs as a percentage of sales from 25.24% to 25.39% was a component in the falling net income despite rising revenues.
| Gross margin | 45.59% |
|---|---|
| Net profit margin | 10.33% |
| Operating margin | 13.15% |
| Return on assets | 7.13% |
|---|---|
| Return on equity | 11.30% |
| Return on investment | 13.12% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Humanwell Healthcare Group Co Ltd fell by 1.35bn. However, the company earned 1.97bn from its operations for a Cash Flow Margin of 8.02%. In addition the company used 1.22bn on investing activities and also paid 2.11bn in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 10.95 |
|---|---|
| Tangible book value per share | 8.73 |
More ▼
Balance sheet in CNYView more
| Current ratio | 1.49 |
|---|---|
| Quick ratio | 1.21 |
| Total debt/total equity | 0.5462 |
|---|---|
| Total debt/total capital | 0.3171 |
More ▼
Growth rates in CNY
Year on year, growth in dividends per share increased 187.50% while earnings per share excluding extraordinary items fell by -14.94%. The positive trend in dividend payments is noteworthy since very few companies in the Major Drugs industry pay a dividend.
| Div yield(5 year avg) | 0.78% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 50.92% |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -0.4526 |
More ▼
